MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-17-2026
Capricor Therapeutics Depreciation & Amortization 2011-2026 | CAPR
Annual Depreciation & Amortization Capricor Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.89 M | 1.43 M | 1.07 M | 533 K | 246 K | 144 K | 172 K | 158 K | 144 K | 126 K | 111 K | 41.9 K | 26.9 K | 20.3 K | 7.51 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.89 M | 7.51 K | 408 K |
Quarterly Depreciation & Amortization Capricor Therapeutics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 495 K | 486 K | 405 K | - | 361 K | 357 K | 331 K | - | 276 K | 255 K | 230 K | - | 137 K | 112 K | 92.5 K | - | 167 K | 102 K | 50.1 K | - | 102 K | 65.6 K | 33 K | - | 129 K | 86.4 K | 43.3 K | - | 114 K | 73 K | 34.1 K | - | 110 K | 76.1 K | 38.8 K | - | 91.8 K | 65.1 K | 31.6 K | - | 79.8 K | 51 K | 24.8 K | - | 28.4 K | 16.2 K | 6.46 K | - | 20.4 K | 13.8 K | 6.12 K | - | 4.81 K | 3.36 K | 1.79 K | - | 5.88 K | 4.07 K | 2.19 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 495 K | 1.79 K | 116 K |
Depreciation & Amortization of other stocks in the Biotechnology industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Assembly Biosciences
ASMB
|
129 K | $ 28.46 | 3.45 % | $ 319 M |  USA |
 |
Axsome Therapeutics
AXSM
|
503 K | $ 156.92 | -1.23 % | $ 7.81 B | USA |
 |
Galera Therapeutics
GRTX
|
20 K | - | -32.59 % | $ 7.61 M | USA |
 |
Pharming Group N.V.
PHAR
|
7.28 M | $ 15.36 | -0.71 % | $ 7.59 B |  Niderland |
 |
Autolus Therapeutics plc
AUTL
|
7.55 M | $ 1.37 | -4.2 % | $ 350 M |  Britain |
 |
I-Mab
IMAB
|
23.9 M | - | - | $ 866 M |  China |
 |
Benitec Biopharma
BNTC
|
66 K | $ 10.98 | -4.52 % | $ 452 M | USA |
 |
Compugen Ltd.
CGEN
|
461 K | $ 2.09 | -0.95 % | $ 195 M |  Israel |
 |
ARCA biopharma
ABIO
|
27 K | - | 1052.0 % | $ 415 M | USA |
 |
Aeterna Zentaris
AEZS
|
58 K | - | 5.93 % | $ 314 M |  Canada |
 |
Applied Genetic Technologies Corporation
AGTC
|
1.51 M | - | - | $ 26.5 M | USA |
 |
PainReform Ltd.
PRFX
|
7 K | $ 2.28 | -0.44 % | $ 1.03 M | Israel |
 |
Acorda Therapeutics
ACOR
|
31.7 M | - | -24.86 % | $ 820 K | USA |
 |
Acasti Pharma
ACST
|
7 K | - | 4.01 % | $ 150 M | Canada |
|
Foghorn Therapeutics
FHTX
|
3.33 M | $ 5.0 | 2.25 % | $ 315 M | USA |
 |
Adverum Biotechnologies
ADVM
|
3.65 M | - | - | $ 86.2 M | USA |
 |
Acer Therapeutics
ACER
|
66 K | - | 2.71 % | $ 14 M | USA |
 |
Advaxis
ADXS
|
369 K | - | -9.65 % | $ 45.9 M | USA |
 |
AbCellera Biologics
ABCL
|
18.4 M | $ 3.4 | -3.68 % | $ 1.02 B | Canada |
 |
BioMarin Pharmaceutical
BMRN
|
79.6 M | $ 54.13 | -1.64 % | $ 10.4 B | USA |
 |
Curis
CRIS
|
203 K | $ 0.77 | 1.89 % | $ 4.86 M | USA |
 |
AgeX Therapeutics
AGE
|
131 K | - | -10.17 % | $ 12.2 K | USA |
 |
Coherus BioSciences
CHRS
|
1.3 M | $ 1.52 | -5.59 % | $ 178 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
744 K | - | - | $ 1.01 B | USA |
 |
Akero Therapeutics
AKRO
|
18 K | - | - | $ 3.67 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
1.4 M | $ 4.24 | -2.97 % | $ 704 M | Canada |
 |
Akouos
AKUS
|
2.49 M | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
274 K | - | -0.23 % | $ 916 M | USA |
 |
AIkido Pharma
AIKI
|
105 K | - | 1.93 % | $ 17.4 M | USA |
 |
Cardiff Oncology
CRDF
|
364 K | $ 1.8 | -1.1 % | $ 120 M | USA |
 |
Allakos
ALLK
|
6.14 M | - | - | $ 28.6 M | USA |
 |
Cabaletta Bio
CABA
|
1.43 M | $ 2.94 | -3.29 % | $ 3.43 M | USA |
 |
Iterum Therapeutics
ITRM
|
30 K | $ 0.16 | -5.45 % | $ 3.15 M |  Irlanda |
 |
Brickell Biotech
BBI
|
41 K | - | -5.38 % | $ 6.06 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
363 K | - | 3.16 % | $ 1.9 M | USA |